Other

iHealth COVID-19 Antigen Rapid Test

• 83/100 science score
• $14.99 price
• Promoted by Mikhail Varshavski

Overview

This product scores highly due to robust FDA-validated clinical performance: 94.3% PPA and 98.1% NPA in symptomatic early infection from a study of 139 participants vs RT-PCR, with serial testing boosting detection to near 100%. Omicron-specific evaluation showed 73% sensitivity, comparable to non-Omicron and other RATs like BinaxNOW (69.7%), confirming reliability across variants. Safety is excellent with only minor topical irritant risks from buffer chemicals at low concentrations (0.1% Triton

Key strengths

• FDA EUA with high PPA (94.3%) and NPA (98.1%) in clinical studies
• Effective serial testing for symptomatic/asymptomatic use
• App-based results and variant performance (e.g., Omicron 73% sens)

Our analysis

The iHealth COVID-19 Antigen Rapid Test is a reliable, FDA-authorized at-home option with strong clinical evidence for early symptomatic detection via serial testing. Suitable for home use in high-risk settings, but confirm negatives with PCR if symptoms persist. Excellent value comparable to leading alternatives.

Frequently asked questions

Is iHealth COVID-19 Antigen Rapid Test worth buying?

iHealth COVID-19 Antigen Rapid Test has a Verify Influencers trust score of 83/100 based on ingredient quality, clinical evidence, and third-party testing.

What is the trust score for iHealth COVID-19 Antigen Rapid Test?

iHealth COVID-19 Antigen Rapid Test scored 83 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored